Racial differentials in the identification of hypercholesterolemia
Related Experiment Video
Updated: Nov 7, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
E H Naumburg1, P Franks, B Bell
1Department of Family Medicine, University of Rochester, New York.
Insights
Racial minorities are less likely to be screened for high cholesterol and diagnosed with hypercholesterolemia compared to white Americans. This suggests disparities in healthcare provider behavior influence cardiovascular risk management.
Area of Science:
- Cardiovascular Disease Epidemiology
- Health Disparities Research
- Clinical Practice Analysis
Background:
- African Americans experience higher cardiovascular disease (CVD) rates than white Americans.
- Identifying barriers to CVD risk reduction is crucial for addressing racial disparities.
- This study investigates race-based differences in hypercholesterolemia screening and diagnosis.
Purpose of the Study:
- To examine the association between patient race and the likelihood of receiving cholesterol screening.
- To determine if race influences the diagnosis of hypercholesterolemia among screened patients.
- To identify potential provider behavior variations contributing to CVD risk management disparities.
Main Methods:
- Prospective data collection from a family medicine residency program (N=4256).
- Multivariate analyses controlled for age, sex, insurance, socioeconomic status, visit frequency, and other CVD risk factors.
- Inclusion criteria: complete data on demographics and cardiovascular risk factors.
Main Results:
- Minorities were less likely than whites to be screened for cholesterol (adjusted odds ratio [AOR] = 0.84).
- No significant difference in mean cholesterol levels was observed between racial groups.
- Screened minorities were less likely to be diagnosed with hypercholesterolemia than whites (AOR = 0.62), particularly those with high cholesterol levels (AOR = 0.47).
Conclusions:
- Provider behavior in diagnosing hypercholesterolemia appears to vary significantly by patient race.
- These findings highlight potential racial biases in clinical decision-making impacting CVD risk management.
- Further research is needed to address these disparities and improve equitable cardiovascular care.
Background:
African Americans have higher rates of cardiovascular disease than white Americans. To address this differential, barriers to cardiovascular risk reduction need to be identified. This study examines the association of race with the likelihood of screening for and diagnosis of hypercholesterolemia.
Methods:
Possible associations between demographic variables and screening for and diagnosis of hypercholesterolemia were examined on data gathered in a prospective fashion in an office-based family medicine residency training program in Rochester, New York. A consecutive sample of all patients seen between December 15, 1988, and April 15, 1990, about whom there was complete data collection (age, sex, insurance, race, and other cardiovascular risk factors) were included in the multivariate analyses (N = 4256).
Results:
After controlling for age, sex, insurance status, socioeconomic status, number of visits, and other cardiovascular risk factors, it was found that minorities were less likely to have been screened for cholesterol levels than whites (adjusted odds ratio [AOR] = 0.84, 95% confidence interval [CI] = 0.98 to 0.72). The mean cholesterol level did not differ by race (mean cholesterol for whites, 204 mg/dL [5.28 mmol/L], and for minorities, 203 mg/dL [5.25 mmol/L], t = 0.7, P = .47). Among those screened, minorities were less likely than whites to have been diagnosed with hypercholesterolemia (AOR = 0.62, 95% CI = 0.86 to 0.44; and 0.47 (95% CI = 0.28 to 0.78] in those with a cholesterol level greater than 240 mg/dL [6.2 mmol/L]).
Conclusions:
Our data suggest that provider behavior in diagnosing hypercholesterolemia varies by the race of the patient.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Lipids: Dietary Sources and Requirements
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
